Dataset Information


Potential of Pseudoshikonin I Isolated from Lithospermi Radix as Inhibitors of MMPs in IL-1?-Induced SW1353 Cells.

ABSTRACT: Pseudoshikonin I, the new bioactive constituent of Lithospermi radix, was isolated from this methanol extract by employing reverse-phase medium-pressure liquid chromatography (MPLC) using acetonitrile/water solvent system as eluents. The chemical structure was determined based on spectroscopic techniques, including 1D NMR (¹H, (13)C, DEPT), 2D NMR (gCOSY, gHMBC, gHMQC), and QTOF/MS data. In this study, we demonstrated the effect of pseudoshikonin I on matrix-metalloproteinase (MMPs) activation and expression in interleukin (IL)-1?-induced SW1353 chondrosarcoma cells. MMPs are considered important for the maintenance of the extracellular matrix. Following treatment with PS, active MMP-1, -2, -3, -9, -13 and TIMP-2 were quantified in the SW1353 cell culture supernatants using a commercially available ELISA kit. The mRNA expression of MMPs in SW1353 cells was measured by RT-PCR. Pseudoshikonin I treatment effectively protected the activation on all tested MMPs in a dose-dependent manner. TIMP-2 mRNA expression was significantly upregulated by pseudoshikonin I treatment. Overall, we elucidated the inhibitory effect of pseudoshikonin on MMPs, and we suggest its use as a potential novel anti-osteoarthritis agent.


PROVIDER: S-EPMC5000746 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC6270163 | BioStudies
2015-01-01 | S-EPMC6272199 | BioStudies
1000-01-01 | S-EPMC6269660 | BioStudies
2014-01-01 | S-EPMC4080812 | BioStudies
2020-01-01 | S-EPMC6974738 | BioStudies
2012-01-01 | S-EPMC3493509 | BioStudies
2009-01-01 | S-EPMC2649432 | BioStudies
2017-01-01 | S-EPMC5666880 | BioStudies
1000-01-01 | S-EPMC2631003 | BioStudies
2012-01-01 | S-EPMC3306414 | BioStudies